eMedCodes logo

Treatment Set TS348405 - Treatment Set TS348405

Navigation: NDC > Supplier starting with: A > ANTIGEN LABORATORIES, INC.
Field Value
NDC Code: 49288-0895
Proprietary Name: Treatment Set TS348405
Suffix:
Non-Proprietary Name: Treatment Set TS348405
Dosage Form: INJECTION, SOLUTION
Method: INTRADERMAL; SUBCUTANEOUS
Original Marketing Date: 31-10-1986
Category Name: BLA
Application Number: BLA102223
Labeler: ANTIGEN LABORATORIES, INC.
Substance Name: ALTERNARIA ALTERNATA; AVENA SATIVA POLLEN; CYNODON DACTYLON POLLEN; FESTUCA PRATENSIS POLLEN; PERIPLANETA AMERICANA; PHLEUM PRATENSE POLLEN; SORGHUM HALEPENSE POLLEN
Active Numerator Strength: .00008; .002; 80; 20000; .01; 20000; .0004
Active Ingredient Unit: g/mL; g/mL; [BAU]/mL; [BAU]/mL; g/mL; [BAU]/mL; g/mL
Pharm Classes: Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]
DEA Schedule: